NEW YORK (GenomeWeb News) — Affymetrix late yesterday said it has filed additional patent-infringement lawsuits against Illumina in the US, UK, and Germany claiming that the genome-analysis and array technologies Illumina acquired when it bought Solexa, as well as all of Illumina’s BeadArray products, infringe certain of its patents.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.